Skip to main content
. 2023 Apr 4;13(4):613. doi: 10.3390/brainsci13040613

Table 1.

Demographic, sleep and clinical measures of the participants. Key: ISI—Insomnia severity index; PSQI—Pittsburgh sleep quality index; CSM—Composite Scale of Morningness; DBAS—Dysfunctional beliefs about sleep; GAD-7—Generalised Anxiety Disorder; PHQ-9—Patient Health Questionnaire; DLMO—dim light melatonin onset; PSG—polysomnography; TST—total sleep time; SOL—sleep onset latency; WASO—wake after sleep onset; HBTd—habitual bedtime sleep diary. Note: one participant recorded zero minutes on the PSG recording which was not recorded in the ranges.

Variable Mean ± SD (Range)
n = 115
Age (years): SD 47.1 ± 14.8 (18–80)
BMI (kg/m2) 25.6 ± 5.3 (17.1–43.8)
Female: n (%) 80 (70%)
ISI 19.9 ± 4.2 (10–28)
PSQI 13.1 ± 3.3 (5–20)
CSM 35.0 ± 8.3 (14–52)
DBAS 5.7 ± 1.6 (1–9)
GAD-7 7.2 ± 4.9 (0–21)
PHQ-9 10.8 ± 5.5 (2–24)
DLMO (hh:mm) (n = 98) 21:12 ± 1:28 (17:28–0:32)
PSG: TST (min) 344.2 ± 77.1 (156.0–518.5)
PSG: SOL (min) 22.0 ± 26.4 (1.0–159.0)
PSG: WASO (min) 86.0 ± 54.4 (7.0–249.5)
PSG: sleep efficiency (%) 74.1 ± 14.4 (43.5–94.4)
Diary: TST (min) 346.6 ± 87.2 (135.0–557.1)
Diary: SOL (min) 43.0 ± 39.0 (5.6–180.0)
Diary: WASO (min) 57.6 ± 50.0 (2–252.0)
Diary: sleep efficiency (%) 75.7 ± 15.2 (39.1–98.2)
Phase angle HBTd—DLMO (min) 96.3 ± 88.6 (−108–276)